Test Price
2,700 AED✅ Home Collection Available
Cultured AFB Drug Resistance (Anti‑Tubercular DST) Rapid 15‑Drug Panel – Dubai, UAE | 2,700 AED
Executive Summary & Core Metrics
Executive Summary: This comprehensive panel profiles Mycobacterium tuberculosis susceptibility against 15 first‑ and second‑line antitubercular agents using automated fluorescent technology (BACTEC MGIT 960). With a diagnostic sensitivity of 99.9% and ISO‑certified processing, it delivers actionable results to guide personalized treatment for drug‑resistant tuberculosis.
Premium Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval is arranged for pure culture isolates. No home phlebotomy is available for this test; collection is strictly via temperature‑controlled courier from referring laboratories or hospitals across Dubai, Abu Dhabi, and Sharjah.
Clinical Guidance: Complimentary telephonic post‑test clinical guidance for result interpretation.
Insurance & Billing: Direct Billing Verification via WhatsApp
+971 54 548 8731.
Test Overview & Methodology
The Cultured AFB Drug Resistance (Anti‑Tubercular DST) Rapid 15‑Drug Panel is the gold standard for determining the drug susceptibility profile of Mycobacterium tuberculosis complex. Using automated liquid culture technology (BACTEC MGIT 960), this panel evaluates 15 antitubercular agents simultaneously, reducing turnaround time from the conventional 4–6 weeks to just 21 days while maintaining 99.9% sensitivity. This precision enables clinicians to rapidly adjust therapy for multi‑drug resistant tuberculosis (MDR‑TB) and extensively drug‑resistant tuberculosis (XDR‑TB).
| Feature | Our Test | Conventional DST |
|---|---|---|
| Methodology | Automated Fluorescent (BACTEC MGIT 960) | LJ Proportion Method |
| Drugs Tested | 15 first‑ & second‑line agents | 4–6 core drugs only |
| Turnaround Time | 21 days | 4–6 weeks |
| Clinical Precision | 99.9% sensitivity | 85–90% |
Physician Insight & Safety Protocols
A Note from Dr. Ajay Singh, General Practitioner (DHA: 36234132):
“I understand the anxiety that comes with a tuberculosis diagnosis, especially when drug resistance is suspected. This 15‑drug panel eliminates guesswork by providing a clear susceptibility map of your specific bacterial strain. Remember, laboratory results must always be correlated with your imaging studies, clinical signs, and overall health status for a safe treatment plan. Never adjust your medication without consulting your physician.”
Advisory: Medication Safety
⚠️ Medication Warning: Do not discontinue or modify any prescribed anti‑tubercular treatment without explicit consultation with your treating physician. Abrupt changes can foster further resistance.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion for Courier Collection: Active hemoptysis (coughing up blood), severe dyspnea at rest, or acute chest trauma require immediate hospital evaluation – do not schedule courier pick‑up.
- Specimen Rejection: Non‑sterile container, leakage, improper transport temperature, or non‑viable culture. Pure growth on solid/liquid media must be in a sterile screw‑capped container sealed inside a biohazard bag.
- Red Flags – Seek Immediate Emergency Care: Massive hemoptysis, sudden pleuritic chest pain with high fever/rigors, confusion, or bluish discoloration of lips.
Patient FAQ & Clinical Guidance
1. What exactly does the 15‑drug anti‑tubercular DST panel detect?
This panel precisely detects Mycobacterium tuberculosis susceptibility to 15 anti‑tuberculosis drugs, including first‑line agents (isoniazid, rifampin, ethambutol, pyrazinamide) and second‑line agents (fluoroquinolones, aminoglycosides, and others). The results guide optimal therapy for drug‑resistant TB.
2. How long does it take to receive the results?
Final drug‑susceptibility results are reported within 21 days due to mycobacterial growth kinetics. Earlier preliminary flags may be available if resistance to key drugs is detected sooner.
3. How is the specimen collected for this test?
This test requires a pure culture isolate of Mycobacterium tuberculosis. Collection is arranged via secure medical courier solid tissue specimen retrieval from your referring laboratory or hospital. No home phlebotomy is offered for this test. Our team coordinates the pickup and ensures temperature‑controlled transport (2–8°C) to our DHA‑licensed facility.
UAE Regulatory & Data Privacy Adherence
This test is conducted under the DHA Facility License No. 1143 and fully complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted and handled in accordance with DHA and MOHAP regulations. Clinical safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Cultured AFB Drug Resistance (Anti‑Tubercular DST) Rapid 15‑Drug Panel |
| Price (AED) | 2,700 AED |
| Turnaround Time | 21 days |
| Sample Type / Matrix | Cultured Isolate (Mycobacterium tuberculosis complex) on solid/liquid media |
| Methodology Used | Automated Liquid Culture Drug Susceptibility Testing (BACTEC MGIT 960) |
| ICD-10-CM Code | A15.0 (Tuberculosis of lung) / Z16.3 (Resistance to antimicrobial drugs) |
| LOINC Code | 88122-7 (Mycobacterium tuberculosis drug susceptibility panel) |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians